Search research articles
Contact Us
Filters
Showing results (1021-1030 of 1,153) with videos related to
Page
of 116
Sort By:
Blood
|
November 8, 2019
Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles
Annette M Staiger, Eva Hoster, Vindi Jurinovic, et al.
Blood
|
December 21, 2018
The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma
Rabea Wagener, Julian Seufert, Francesco Raimondi, et al.
Haematologica
|
November 3, 2009
Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials
Heinz-Wolfram Bernd, Marita Ziepert, Christoph Thorns, et al.
Blood
|
October 29, 2025
High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition
Leila Ronceray, Minke H W Huibers, Katrin Reutter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2019
Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial
Hanneke C Kluin-Nelemans, Eva Hoster, Olivier Hermine, et al.
Blood Advances
|
June 3, 2026
EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma
Ananth G Shankar, Judith Landman-Parker, Maurizio Mascarin, et al.
EMBO Molecular Medicine
|
June 19, 2016
USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma
Katharina Engel, Martina Rudelius, Jolanta Slawska, et al.
Pediatric Blood & Cancer
|
November 15, 2018
Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial
L Kurch, D Hasenclever, R Kluge, et al.
Hemasphere
|
August 17, 2022
Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas
Heike Horn, Vindi Jurinovic, Ellen Leich, et al.
Vaccines
|
November 11, 2022
SARS-CoV-2 IgG Antibody Levels in Women with IBD Vaccinated during Pregnancy
Irit Avni Biron, Yair Maayan, Tali Mishael, et al.
Page
of 116
Search research articles
Search
Showing results (1021-1030 of 1,153) with videos related to
Sort By:
Page
of 116
Blood
|
November 8, 2019
Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles
Annette M Staiger, Eva Hoster, Vindi Jurinovic, et al.
Blood
|
December 21, 2018
The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma
Rabea Wagener, Julian Seufert, Francesco Raimondi, et al.
Haematologica
|
November 3, 2009
Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials
Heinz-Wolfram Bernd, Marita Ziepert, Christoph Thorns, et al.
Blood
|
October 29, 2025
High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition
Leila Ronceray, Minke H W Huibers, Katrin Reutter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2019
Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial
Hanneke C Kluin-Nelemans, Eva Hoster, Olivier Hermine, et al.
Blood Advances
|
June 3, 2026
EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma
Ananth G Shankar, Judith Landman-Parker, Maurizio Mascarin, et al.
EMBO Molecular Medicine
|
June 19, 2016
USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma
Katharina Engel, Martina Rudelius, Jolanta Slawska, et al.
Pediatric Blood & Cancer
|
November 15, 2018
Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial
L Kurch, D Hasenclever, R Kluge, et al.
Hemasphere
|
August 17, 2022
Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas
Heike Horn, Vindi Jurinovic, Ellen Leich, et al.
Vaccines
|
November 11, 2022
SARS-CoV-2 IgG Antibody Levels in Women with IBD Vaccinated during Pregnancy
Irit Avni Biron, Yair Maayan, Tali Mishael, et al.
Page
of 116